{"id":787,"date":"2026-09-01T17:35:05","date_gmt":"2026-09-01T17:35:05","guid":{"rendered":"https:\/\/nhdbio.com\/resources\/sermorelin-gh-response-human-evidence-review\/"},"modified":"2026-09-08T07:30:41","modified_gmt":"2026-09-08T07:30:41","slug":"revue-des-donnees-cliniques-sur-la-reponse-au-sermorelin-gh-chez-letre-humain","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/fr\/sermorelin-gh-response-human-evidence-review\/","title":{"rendered":"Preuve humaine Sermorelin\u00a0: tests de r\u00e9ponse GH et limites historiques"},"content":{"rendered":"
Sermorelin est un GHRH(1\u201329)-amide. La recherche humaine montre des r\u00e9ponses aigu\u00ebs de l'hormone de croissance hypophysaire, tandis que les donn\u00e9es historiques sur les traitements sont limit\u00e9es et ne soutiennent pas les all\u00e9gations modernes en mati\u00e8re d'anti-\u00e2ge ou de performance.<\/p>
Les preuves en un coup d'\u0153il<\/h2>
Une \u00e9tude sur des sujets normaux a r\u00e9v\u00e9l\u00e9 des augmentations maximales comparables de GH apr\u00e8s GRF1-44, GRF1-40 et GRF1-29.<\/li>
Une \u00e9tude \u00e0 faible dose a r\u00e9v\u00e9l\u00e9 des r\u00e9ponses maximales moyennes significatives de GH apr\u00e8s 10 et 100 \u00b5g, mais pas 1 \u00b5g, GHRH(1\u201329)-amide.<\/li>
Une revue p\u00e9diatrique a d\u00e9crit des donn\u00e9es limit\u00e9es sur la hauteur et la vitesse et a d\u00e9clar\u00e9 que les effets finaux sur la taille adulte et la comparaison directe avec la somatropine n'\u00e9taient pas r\u00e9solus.<\/li><\/ul><\/div><\/div>Illustration \u00e9ditoriale g\u00e9n\u00e9r\u00e9e par AI illustrant le flux de travail de recherche. Il ne s\u2019agit pas d\u2019une figure d\u2019\u00e9tude, d\u2019une image de patient, d\u2019une photographie de produit, d\u2019un r\u00e9sultat d\u2019analyse ou d\u2019un lot de catalogue.<\/figcaption><\/figure>
Dossier d'\u00e9tudes<\/h2>
Les premiers travaux sur des sujets normaux ont \u00e9tabli que le fragment 1 \u2013 29 conservait son activit\u00e9 biologique. Une administration r\u00e9p\u00e9t\u00e9e \u00e0 des intervalles de six heures a produit des r\u00e9ponses GH, tandis que des intervalles plus courts et une perfusion continue se sont comport\u00e9s diff\u00e9remment. Il s\u2019agissait de questions de physiologie et de diagnostic, pas d\u2019essais de long\u00e9vit\u00e9.<\/p>
Fragment actif<\/strong>GHRH (1 \u2013 29) -amide<\/span><\/div>
Il est temps d'atteindre le sommet<\/strong>15.8 minutes \u00e0 10 \u00b5g\u00a0; 24.8 minutes \u00e0 100 \u00b5g<\/span><\/div>
Examen p\u00e9diatrique<\/strong>Donn\u00e9es pr\u00e9pub\u00e8res limit\u00e9es\u00a0; taille adulte finale non d\u00e9termin\u00e9e<\/span><\/div>
Limite de la revendication<\/strong>Aucune preuve ici sur les r\u00e9sultats en mati\u00e8re d'anti-\u00e2ge, de musculation ou de performance g\u00e9n\u00e9rale<\/span><\/div><\/div><\/div>
R\u00e9sultats en contexte<\/h2>
Dans l\u2019\u00e9tude de r\u00e9ponse \u00e0 faible dose, 10 et 100 \u00b5g ont produit des valeurs maximales de GH similaires, mais la dose la plus \u00e9lev\u00e9e a pr\u00e9sent\u00e9 une diminution plus lente apr\u00e8s le pic et un d\u00e9lai d\u2019obtention du pic plus long. Ces donn\u00e9es illustrent le comportement dose-r\u00e9ponse dans le cadre d'un protocole de test sp\u00e9cifique\u00a0; ils ne doivent pas \u00eatre convertis en instructions non supervis\u00e9es.<\/p>
L'examen p\u00e9diatrique a discut\u00e9 de l'utilisation diagnostique et a s\u00e9lectionn\u00e9 des enfants pr\u00e9sentant un d\u00e9ficit idiopathique en GH. Il a \u00e9galement d\u00e9clar\u00e9 que les effets \u00e0 long terme sur la hauteur finale n'avaient pas \u00e9t\u00e9 d\u00e9termin\u00e9s et que les effets de la dose recommand\u00e9e n'avaient pas \u00e9t\u00e9 directement compar\u00e9s \u00e0 ceux de la somatropine.<\/p>
Ce que la preuve ne peut \u00e9tablir<\/h2>
Les protocoles et tests historiques peuvent ne pas correspondre \u00e0 la pratique actuelle.<\/p>
La lib\u00e9ration aigu\u00eb de GH est un crit\u00e8re d\u2019\u00e9valuation physiologique de substitution.<\/p>
Les preuves cit\u00e9es ne valident pas le marketing anti-\u00e2ge, de composition corporelle ou de performance sportive.<\/p>","protected":false},"excerpt":{"rendered":"
Sermorelin est un GHRH(1\u201329)-amide. La recherche humaine montre des r\u00e9ponses aigu\u00ebs de l'hormone de croissance hypophysaire, tandis que les donn\u00e9es historiques sur les traitements sont limit\u00e9es et ne soutiennent pas les all\u00e9gations modernes en mati\u00e8re d'anti-\u00e2ge ou de performance.<\/p>","protected":false},"author":1,"featured_media":771,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"362","pim_article_type":"Published evidence review","pim_evidence_level":"Historical human physiology and diagnostic studies plus limited pediatric treatment literature","pim_reviewer":"Site evidence editorial team","pim_reviewed_date":"2026-09-02","pim_editorial_note":"Source-checked on 2026-09-02. Null results, sample size, model\/population limits and regulatory scope are retained. This is not medical advice, a customer case or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"Primary and official sources, numerical results, null findings, limitations, product-evidence boundary and image disclosure checked for batch 4.","pim_creation_method":"This article discusses the source records listed below, with the study models and limitations stated alongside the findings. AI-assisted drafting and image generation were used. The reference list identifies the records behind this article; it is not an independent peer review or verification of a supplied catalog lot.","pim_sources":"[{\"title\":\"GRF1-29 stimulation in normal subjects\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/6240568\/\",\"note\":\"Primary human physiology study; PMID 6240568.\"},{\"title\":\"Low-dose GHRH(1\u201329)-amide dose-response study\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/7921207\/\",\"note\":\"Primary human dose-response study; PMID 7921207.\"},{\"title\":\"Sermorelin pediatric review\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18031173\/\",\"note\":\"Historical diagnostic and pediatric treatment review; PMID 18031173.\"},{\"title\":\"GHRH analog detection in human plasma\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26879649\/\",\"note\":\"Validated LC-HRMS\/MS method; PMID 26879649.\"},{\"title\":\"PubChem Sermorelin record\",\"url\":\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Sermorelin\",\"note\":\"Sequence, formula and molecular weight; CID 16132413.\"}]","footnotes":""},"categories":[19],"tags":[],"class_list":["post-787","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-published-study-cases"],"yoast_head":"\n
Sermorelin Human Evidence: GH Response Tests and Historical Limits<\/title>\n<meta name=\"description\" content=\"Sermorelin is GHRH(1\u201329)-amide. Human research shows acute pituitary growth-hormone responses, while historical treatment data are limited and do not suppo\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/fr\/revue-des-donnees-cliniques-sur-la-reponse-au-sermorelin-gh-chez-letre-humain\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sermorelin Human Evidence: GH Response Tests and Historical Limits\" \/>\n<meta property=\"og:description\" content=\"Sermorelin is GHRH(1\u201329)-amide. Human research shows acute pituitary growth-hormone responses, while historical treatment data are limited and do not suppo\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/fr\/revue-des-donnees-cliniques-sur-la-reponse-au-sermorelin-gh-chez-letre-humain\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-01T17:35:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-08T07:30:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/sermorelin-evidence.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/sermorelin-gh-response-human-evidence-review\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/sermorelin-gh-response-human-evidence-review\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"Sermorelin Human Evidence: GH Response Tests and Historical Limits\",\"datePublished\":\"2026-09-01T17:35:05+00:00\",\"dateModified\":\"2026-09-08T07:30:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/sermorelin-gh-response-human-evidence-review\\\/\"},\"wordCount\":311,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/sermorelin-gh-response-human-evidence-review\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/sermorelin-evidence.webp\",\"articleSection\":[\"Published Study Reviews\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/sermorelin-gh-response-human-evidence-review\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/sermorelin-gh-response-human-evidence-review\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/sermorelin-gh-response-human-evidence-review\\\/\",\"name\":\"Sermorelin Human Evidence: GH Response Tests and Historical Limits\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/sermorelin-gh-response-human-evidence-review\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/sermorelin-gh-response-human-evidence-review\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/sermorelin-evidence.webp\",\"datePublished\":\"2026-09-01T17:35:05+00:00\",\"dateModified\":\"2026-09-08T07:30:41+00:00\",\"description\":\"Sermorelin is GHRH(1\u201329)-amide. Human research shows acute pituitary growth-hormone responses, while historical treatment data are limited and do not suppo\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/sermorelin-gh-response-human-evidence-review\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/sermorelin-gh-response-human-evidence-review\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/sermorelin-gh-response-human-evidence-review\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/sermorelin-evidence.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/sermorelin-evidence.webp\",\"width\":1672,\"height\":941,\"caption\":\"AI-generated illustration: endocrine laboratory reviewing timed hormone samples\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/sermorelin-gh-response-human-evidence-review\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sermorelin Human Evidence: GH Response Tests and Historical Limits\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/fr\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Preuve humaine Sermorelin\u00a0: tests de r\u00e9ponse GH et limites historiques","description":"Sermorelin est un GHRH(1\u201329)-amide. La recherche humaine montre des r\u00e9ponses aigu\u00ebs de l'hormone de croissance hypophysaire, alors que les donn\u00e9es historiques sur les traitements sont limit\u00e9es et ne soutiennent pas\u2026","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/fr\/revue-des-donnees-cliniques-sur-la-reponse-au-sermorelin-gh-chez-letre-humain\/","og_locale":"fr_FR","og_type":"article","og_title":"Sermorelin Human Evidence: GH Response Tests and Historical Limits","og_description":"Sermorelin is GHRH(1\u201329)-amide. Human research shows acute pituitary growth-hormone responses, while historical treatment data are limited and do not suppo\u2026","og_url":"https:\/\/nhdbio.com\/fr\/revue-des-donnees-cliniques-sur-la-reponse-au-sermorelin-gh-chez-letre-humain\/","og_site_name":"NHD","article_published_time":"2026-09-01T17:35:05+00:00","article_modified_time":"2026-09-08T07:30:41+00:00","og_image":[{"width":1672,"height":941,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/sermorelin-evidence.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"\u00c9crit par":"NHD Technical Team","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/sermorelin-gh-response-human-evidence-review\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/sermorelin-gh-response-human-evidence-review\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"Sermorelin Human Evidence: GH Response Tests and Historical Limits","datePublished":"2026-09-01T17:35:05+00:00","dateModified":"2026-09-08T07:30:41+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/sermorelin-gh-response-human-evidence-review\/"},"wordCount":311,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/sermorelin-gh-response-human-evidence-review\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/sermorelin-evidence.webp","articleSection":["Published Study Reviews"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/sermorelin-gh-response-human-evidence-review\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/sermorelin-gh-response-human-evidence-review\/","url":"https:\/\/nhdbio.com\/sermorelin-gh-response-human-evidence-review\/","name":"Preuve humaine Sermorelin\u00a0: tests de r\u00e9ponse GH et limites historiques","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/sermorelin-gh-response-human-evidence-review\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/sermorelin-gh-response-human-evidence-review\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/sermorelin-evidence.webp","datePublished":"2026-09-01T17:35:05+00:00","dateModified":"2026-09-08T07:30:41+00:00","description":"Sermorelin est un GHRH(1\u201329)-amide. La recherche humaine montre des r\u00e9ponses aigu\u00ebs de l'hormone de croissance hypophysaire, alors que les donn\u00e9es historiques sur les traitements sont limit\u00e9es et ne soutiennent pas\u2026","breadcrumb":{"@id":"https:\/\/nhdbio.com\/sermorelin-gh-response-human-evidence-review\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/sermorelin-gh-response-human-evidence-review\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/nhdbio.com\/sermorelin-gh-response-human-evidence-review\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/sermorelin-evidence.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/sermorelin-evidence.webp","width":1672,"height":941,"caption":"AI-generated illustration: endocrine laboratory reviewing timed hormone samples"},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/sermorelin-gh-response-human-evidence-review\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"Sermorelin Human Evidence: GH Response Tests and Historical Limits"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Mati\u00e8res premi\u00e8res peptidiques et synth\u00e8se sur mesure","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"\u00c9quipe technique NHD","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"L'\u00e9quipe technique NHD maintient la documentation du catalogue d'utilisation de la recherche et les r\u00e9sum\u00e9s des preuves. Les articles examin\u00e9s renvoient \u00e0 des articles \u00e9valu\u00e9s par des pairs, \u00e0 des registres d'essais et \u00e0 des dossiers r\u00e9glementaires, conservent les r\u00e9sultats nuls et les limites des \u00e9tudes, et distinguent les interventions publi\u00e9es des documents du catalogue. Le dessin assist\u00e9 par AI peut \u00eatre utilis\u00e9 pour la structure\u00a0; les liens vers les sources et les limites des preuves restent visibles. Ce travail ne constitue pas un examen ind\u00e9pendant par des pairs ni un avis m\u00e9dical.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/fr\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts\/787","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/comments?post=787"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts\/787\/revisions"}],"predecessor-version":[{"id":1200,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts\/787\/revisions\/1200"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/media\/771"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/media?parent=787"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/categories?post=787"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/tags?post=787"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![\"Un](\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/sermorelin-evidence.webp\")